roflumilast
NDC 73190-086, ROFLUMILAST, tablet, from AvKARE.
- Product NDC
- 73190-086
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208247
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73190-086 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73190-086-28 | 73190008628 | 2 BLISTER PACK in 1 BOX (73190-086-28) / 14 TABLET in 1 BLISTER PACK (73190-086-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/55009549-3f0c-1f58-e063-6294a90a6c03
Use it
Look up 73190-086 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73190-086 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73190-086. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.